George Svokos Insider Trading $AMRI ALBANY MOLECULAR RESEARCH INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for George Svokos.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of George Svokos. George Svokos is Chief Commercial Officer in ALBANY MOLECULAR RESEARCH INC ($AMRI) and Chief Operating Officer in ALBANY MOLECULAR RESEARCH INC ($AMRI).
George Svokos in ALBANY MOLECULAR RESEARCH INC
Trading Symbol: AMRIIndustry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of George Svokos: Chief Operating Officer, Chief Commercial Officer
Holdings: 129,150 shares
Current Value: $2,381,526
Latest Transaction: Sep 05 2017
$AMRI Market Capitalization: $765.67M
$AMRI Previous Close: $18.44
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of George Svokos in ALBANY MOLECULAR RESEARCH INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Operating Off ... | Option Exercise | D | 18.41 | 56,818 | 1,046,019 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Operating Off ... | Option Exercise | D | 15.77 | 42,145 | 664,627 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Operating Off ... | Option Exercise | D | 17.05 | 19,078 | 325,280 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Operating Off ... | Option Exercise | D | 10.43 | 29,167 | 304,212 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Operating Off ... | Option Exercise | D | 10.25 | 100,000 | 1,025,000 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Operating Off ... | Sell | D | 21.75 | 129,150 | 2,809,013 | 0 | 129.2 K to 0 (-100.00 %) |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Operating Off ... | Grant | A | 0.00 | 6,064 | 0 | 129,150 | 123.1 K to 129.2 K (+4.93 %) |
Jul 06 2017 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Operating Off ... | Grant | A | 16.04 | 1,324 | 21,237 | 123,086 | 121.8 K to 123.1 K (+1.09 %) |
Mar 06 2017 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Operating Off ... | Payment of Exercise | F | 14.52 | 361 | 5,242 | 121,762 | 122.1 K to 121.8 K (-0.30 %) |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Operating Off ... | Option Exercise | A | 18.41 | 56,818 | 1,046,019 | 56,818 | |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Operating Off ... | Grant | A | 0.00 | 8,663 | 0 | 122,123 | 113.5 K to 122.1 K (+7.64 %) |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Operating Off ... | Grant | A | 0.00 | 11,543 | 0 | 113,460 | 101.9 K to 113.5 K (+11.33 %) |
Feb 07 2017 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Operating Off ... | Payment of Exercise | F | 18.52 | 751 | 13,909 | 101,917 | 102.7 K to 101.9 K (-0.73 %) |
Feb 07 2017 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Operating Off ... | Payment of Exercise | F | 18.52 | 596 | 11,038 | 102,668 | 103.3 K to 102.7 K (-0.58 %) |
Feb 07 2017 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Operating Off ... | Payment of Exercise | F | 18.52 | 2,381 | 44,096 | 103,264 | 105.6 K to 103.3 K (-2.25 %) |
Jan 09 2017 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Operating Off ... | Payment of Exercise | F | 18.98 | 3,535 | 67,094 | 105,645 | 109.2 K to 105.6 K (-3.24 %) |
Nov 03 2016 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Operating Off ... | Payment of Exercise | F | 15.09 | 817 | 12,329 | 109,180 | 110 K to 109.2 K (-0.74 %) |
Jul 07 2016 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Operating Off ... | Grant | A | 11.42 | 1,312 | 14,983 | 109,997 | 108.7 K to 110 K (+1.21 %) |
May 16 2016 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Operating Off ... | Buy | P | 12.82 | 12,500 | 160,250 | 108,685 | 96.2 K to 108.7 K (+13.00 %) |
Mar 04 2016 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Operating Off ... | Payment of Exercise | F | 15.33 | 361 | 5,534 | 96,185 | 96.5 K to 96.2 K (-0.37 %) |
Feb 08 2016 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Operating Off ... | Option Exercise | A | 15.77 | 42,145 | 664,627 | 42,145 | |
Feb 08 2016 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Operating Off ... | Grant | A | 15.77 | 18,390 | 290,010 | 95,026 | 76.6 K to 95 K (+24.00 %) |
Feb 05 2016 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Operating Off ... | Payment of Exercise | F | 16.16 | 596 | 9,631 | 76,636 | 77.2 K to 76.6 K (-0.77 %) |
Feb 05 2016 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Operating Off ... | Grant | A | 16.79 | 58 | 974 | 77,232 | 77.2 K to 77.2 K (+0.08 %) |
Jan 07 2016 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Operating Off ... | Payment of Exercise | F | 18.66 | 3,499 | 65,291 | 77,174 | 80.7 K to 77.2 K (-4.34 %) |
Nov 04 2015 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Operating Off ... | Grant | A | 19.16 | 10,000 | 191,600 | 80,673 | 70.7 K to 80.7 K (+14.15 %) |
Mar 11 2015 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Commercial Of ... | Buy | P | 17.72 | 10,000 | 177,200 | 70,673 | 60.7 K to 70.7 K (+16.48 %) |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Commercial Of ... | Option Exercise | A | 17.05 | 19,078 | 325,280 | 19,078 | |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Chief Commercial Of ... | Grant | A | 17.05 | 8,824 | 150,449 | 60,673 | 51.8 K to 60.7 K (+17.02 %) |
Page: 1